Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intravitreal Combined Aflibercept + Anti-Platelet-Derived Growth Factor Receptor β for Neovascular Age-Related Macular Degeneration: Results of the Phase 2 CAPELLA Trial.
Heier JS, Wykoff CC, Waheed NK, Kitchens JW, Patel SS, Vitti R, Perlee L, Chu KW, Leal S, Asmus F, Son V, Schmelter T, Brown DM. Heier JS, et al. Among authors: perlee l. Ophthalmology. 2020 Feb;127(2):211-220. doi: 10.1016/j.ophtha.2019.09.021. Epub 2019 Sep 25. Ophthalmology. 2020. PMID: 31791663 Clinical Trial.
Risk Alleles Associated with Neovascularization in a Pachychoroid Phenotype.
Dansingani KK, Perlee LT, Hamon S, Lee M, Shah VP, Spaide RF, Sorenson J, Klancnik JM Jr, Yannuzzi LA, Barbazetto IA, Cooney MJ, Engelbert M, Chen C, Hewitt AW, Freund KB. Dansingani KK, et al. Ophthalmology. 2016 Dec;123(12):2628-2630. doi: 10.1016/j.ophtha.2016.06.060. Epub 2016 Aug 6. Ophthalmology. 2016. PMID: 27506487 No abstract available.
Identification of diagnostic biomarkers for infection in premature neonates.
Kingsmore SF, Kennedy N, Halliday HL, Van Velkinburgh JC, Zhong S, Gabriel V, Grant J, Beavis WD, Tchernev VT, Perlee L, Lejnine S, Grimwade B, Sorette M, Edgar JD. Kingsmore SF, et al. Among authors: perlee l. Mol Cell Proteomics. 2008 Oct;7(10):1863-75. doi: 10.1074/mcp.M800175-MCP200. Epub 2008 Jul 13. Mol Cell Proteomics. 2008. PMID: 18622029 Free PMC article.
Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data.
Haab BB, Geierstanger BH, Michailidis G, Vitzthum F, Forrester S, Okon R, Saviranta P, Brinker A, Sorette M, Perlee L, Suresh S, Drwal G, Adkins JN, Omenn GS. Haab BB, et al. Among authors: perlee l. Proteomics. 2005 Aug;5(13):3278-91. doi: 10.1002/pmic.200401276. Proteomics. 2005. PMID: 16038022 Free article.
Pozelimab for CHAPLE disease: results from in-trial interviews and clinical outcome assessments.
Litcher-Kelly L, Ozen A, Ollis S, Feldman HB, Yaworsky A, Medrano P, Chongsrisawa V, Brackin T, Perlee L, Walker M, Pradeep S, Lenardo MJ, Harari OA, Jalbert JJ. Litcher-Kelly L, et al. Among authors: perlee l. Orphanet J Rare Dis. 2024 Aug 8;19(1):290. doi: 10.1186/s13023-024-03277-9. Orphanet J Rare Dis. 2024. PMID: 39118150 Free PMC article. Clinical Trial.
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study.
Ozen A, Chongsrisawat V, Sefer AP, Kolukisa B, Jalbert JJ, Meagher KA, Brackin T, Feldman HB, Baris S, Karakoc-Aydiner E, Ergelen R, Fuss IJ, Moorman H, Suratannon N, Suphapeetiporn K, Perlee L, Harari OA, Yancopoulos GD, Lenardo MJ; Pozelimab CHAPLE Working Group. Ozen A, et al. Among authors: perlee l. Lancet. 2024 Feb 17;403(10427):645-656. doi: 10.1016/S0140-6736(23)02358-9. Epub 2024 Jan 23. Lancet. 2024. PMID: 38278170 Clinical Trial.
25 results